Results 41 to 50 of about 393,410 (301)

Phosphate toxicity and tumorigenesis [PDF]

open access: yesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
In this article, we briefly summarized evidence that cellular phosphate burden from phosphate toxicity is a pathophysiological determinant of cancer cell growth. Tumor cells express more phosphate cotransporters and store more inorganic phosphate than normal cells, and dysregulated phosphate homeostasis is associated with the genesis of various human ...
Brown, Ronald B., Razzaque, Mohammed S.
openaire   +3 more sources

Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis

open access: yes, 2017
Background: This study aimed to investigate whether the DNA methylation of human ovarian carcinoma stromal progenitor cells (OCSPCs) could promote the tumorigenesis of ovarian carcinoma.
鄭文芳   +1 more
core   +1 more source

Genetic dissection of differential signaling threshold requirements for the Wnt/β-catenin pathway in vivo [PDF]

open access: yes, 2010
Contributions of null and hypomorphic alleles of Apc in mice produce both developmental and pathophysiological phenotypes. To ascribe the resulting genotype-to-phenotype relationship unambiguously to the Wnt/beta-catenin pathway, we challenged the allele
Newton, Ian P.   +150 more
core   +2 more sources

The role of antimicrobial peptides in skin tumorigenesis

open access: yes, 2016
Antimicrobial peptides (AMPs), known as “natural antibiotics”, are the first line of defense in humans as effector molecules of the innate immune system of the skin.
Sławomir Majewski   +1 more
core   +1 more source

P53 mutations in human adrenocortical neoplasms [PDF]

open access: yes, 1994
The mechanisms of tumorigenesis of adrenocortical neoplasms have not been elucidated as yet. However, loss of heterozygosity at chromosomal locus 17p has been consistently observed in adrenocortical cancer.
Travis, W.   +6 more
core   +1 more source

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance

open access: yesEMBO Molecular Medicine, 2019
Due to compromised homologous recombination (HR) repair, BRCA1‐ and BRCA2‐mutated tumours accumulate DNA damage and genomic rearrangements conducive of tumour progression.
Eliana MC Tacconi   +23 more
doaj   +1 more source

The roles of the tumor suppressor parafibromin in cancer

open access: yesFrontiers in Cell and Developmental Biology, 2022
In this review, we discuss parafibromin protein, which is encoded by CDC73. A mutation in this gene causes hyperparathyroidism-jaw tumor (HPT-JT) syndrome, an autosomal dominant disease.
Hua-chuan Zheng, Hang Xue, Cong-yu Zhang
doaj   +1 more source

ODAM Expression Inhibits Human Breast Cancer Tumorigenesis

open access: yes, 2011
We have posited that Odontogenic Ameloblast Associated Protein (ODAM) serves as a novel prognostic biomarker in breast cancer and now have investigated its potential role in regulating tumor growth and metastasis.
Jonathan S. Wall   +7 more
core   +1 more source

Estrogen Signaling in Breast Tumorigenesis

open access: yes, 2017
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is believed to activate genes driving tumorigenesis and initial cell proliferation.
Chi, David
core   +6 more sources

RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway

open access: yesFrontiers in Oncology, 2021
Angiogenesis plays an important role in tumor initiation and progression of glioma. Seeking for biomarkers associated with angiogenesis is important in enhancing our understanding of glioma biologically and identifying its new drug targets.
Baoling Liu   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy